Positron-emission mammography may reduce unnecessary breast biopsies, according to data from an NIH-sponsored multisite study. Devices were provided by Naviscan.
Positron-emission mammography may reduce unnecessary breast biopsies, according to data from an NIH-sponsored multisite study. Devices were provided by Naviscan. PEM demonstrated a 6% improvement in specificity compared with breast MR, according to the research. PEM also led to 31 fewer unnecessary biopsies and a 26% higher positive predicative value compared with breast MR.
“The results of this study mean not only do physicians have an additional, powerful tool to help treat breast cancer, but that PEM is a better alternative for the 16% of women who cannot tolerate MR due to claustrophobia, metallic implants, body habitus, or gadolinium reaction,” said Dr. Wendie Berg, principal investigator for the trial and breast imaging specialist at Johns Hopkins Health Care and Surgery Center at Green Spring Station in Lutherville, MD.
The trial examined women from six locations who had newly diagnosed breast cancer. Officials for Naviscan said they have submitted the manuscript to Radiology and anticipate a response by the end of April.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.